Indomethacin for prevention of heterotopic ossification after hip arthroplasty: A randomized comparison between 4 and 8 days of treatment

References

• Ahrengart L, Lindgren U. Heterotopic bone after hip arthroplasty. Defining the patient at risk. Clin Orthop 1993; 293: 153–9
   Google Scholar
• Ahrengart L, Blomgren G, Törnkvist H. Short-term ibuprofen to prevent ossification after hip arthroplasty. No effects in a prospective randomized study of 47 arthrosis cases. Acta Orthop Scand 1994; 65(2)139–41
   PubMed Web of Science ®Google Scholar
• Arcq M. Die paraartikularen Ossifikationen–eine Komp-likation der Totalendoprothese des Huftgelenkes. Arch Orthop Unfall-Chir 1973; 77: 108–31
   Google Scholar
• Bauer R, Kerschbaumer F, Poisel S. Operative Zugangswege in Orthopadie und Traumatologie. Georg Thieme Verlag, Stuttgart 1986
   Google Scholar
• Brooker A F, Bowerman J W, Robinson R A, Riley L H, Jr. Ectopic ossification following total hip replacement. Incidence and method of classification. J Bone Joint Surg (Am) 1973; 55(8)1629–32
   PubMed Web of Science ®Google Scholar
• Cella J P, Salvati E A, Sculco T P. Indomethacin for the prevention of heterotopic ossification following total hip arthroplasty. Effectiveness, contraindications and adverse effects. J Arthroplasty 1988; 3(3)229–34
   PubMedGoogle Scholar
• Dahl H K. Kliniske observasjoner. Symposium on hip arthrosis. Blindem. Merck, Sharp and Dome, Norway 1975; 37–46
   Google Scholar
• DeLee J, Ferrari A, Charnley J. Ectopic bone formation following low friction arthroplasty of the hip. Clin Orthop 1976; 121: 53–9
   Google Scholar
• Elmstedt E, Lindholm T S, Nilsson O S, Tornkvist H. Effect of ibuprofen on heterotopic ossification after hip replacement. Acta Orthop Scand 1985; 56(1)25–7
   PubMed Web of Science ®Google Scholar
• Errico T J, Fetto J F, Waugh T R. Heterotopic ossification. Incidence and relation to trochanteric osteotomy in 100 total hip arthroplasties. Clin Orthop 1984; 190: 138–41
   Google Scholar
• Eyb R, Zweymüller K. Periartikulare Ossifikationen nach Implantation zemenffreier Hufttotalendoprothesen vom Typ Zweymuller Endler. Z Orthop 1985; 123(6)975–80
   PubMed Web of Science ®Google Scholar
• Gebuhr P, Soelberg M, Orsnes T, Wilbek H. Naproxen prevention of heterotopic ossification after total hip arthroplasty. A prospective control study of 55 patients. Acta Orthop Scand 1991; 62(3)226–9
   PubMed Web of Science ®Google Scholar
• Gebuhr P, Sletgard J, Dalsgard J, Soelberg M, Keisu K, Hanninen A, Crawford M. Heterotopic ossification after hip arthroplasty. A randomized double-blind multicenter study of tenoxicam in 147 hips. Acta Orthop Scand 1996; 67(1)29–32
   PubMed Web of Science ®Google Scholar
• Hamblen D L. Ectopic ossification. Complications of total hip replacement, R S M Ling. Churchill Livingstone, London 1984
   Google Scholar
• Hanslik L, Radloff H. Der Krankheitswert paraartikularer Verknocherungen nach total-endoprothetischem Huftge-lenksersatz. Arch Orthop Unfallchir 1974; 80(2)153–64
   PubMedGoogle Scholar
• Hierton C, Blomgren G, Lindgren U. Factors associated with heterotopic bone formation in cemented total hip prosthesis. Acta Orthop Scand 1983; 54: 698–702
   PubMed Web of Science ®Google Scholar
• Hoikka V, Lindholm T S, Eskola A. Flurbiprofen inhibits heterotopic bone formation in total hip arthroplasty. Arch Orthop Trauma Surg 1990; 109(4)224–6
   PubMed Web of Science ®Google Scholar
• Kjaersgaard-Andersen P, Schmidt S A. Indomethacin for prevention of ectopic ossification after hip arthroplasty. Acta Orthop Scand 1986; 57: 12–4
   PubMed Web of Science ®Google Scholar
• Kjaersgaard-Andersen P, Ritter M A. Short-term treatment with nonsteroidal antiinflammatory medications to prevent heterotopic bone formation after total hip arthroplasty. A preliminary report. Clin Orthop 1992; 279: 157–62
   Google Scholar
• Kjaersgaard-Andersen P, Nafei A, Teichert G, Kristensen O, Schmidt S A, Keller J, Lucht U. Indomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasty. Acta Orthop Scand 1993; 64(6)639–42
   PubMed Web of Science ®Google Scholar
• Kromann-Andersen C, Sorensen T S, Hougaard K, Zdravkovic D, Frigaard E. Ectopic bone formation following Charnley hip arthroplasties. Acta Orthop Scand 1980; 51(4)633–8
   PubMedGoogle Scholar
• Maloney W J, Krushell R J, Jasty M, Harris W H. Incidence of heterotopic ossification after total hip replacement: effect on the type of fixation of the femoral component. J Bone Joint Surg (Am) 1991; 73(2)191–3
   PubMed Web of Science ®Google Scholar
• McMahon J S, Waddell J P, Morton J. Effect of short-course indomethacin on heterotopic bone formation after uncemented total hip arthroplasty. J Arthroplasty 1991; 6: 259–64
   PubMedGoogle Scholar
• Metzenroth H, Publig W, Knahr K, Zandl C, Kuchner G, Carda C. Ossifikationsprophylaxe nach Hufttotalen-doprothesen mit Indomethacin und ihr Einfluss auf die Magenschleimhaut. Z Orthop 1991; 129(2)178–82
   PubMed Web of Science ®Google Scholar
• Morrey B F, Adams R A, Cabanela M E. Comparison of heterotopic bone after anterolateral, transtrochanteric and posterior approaches for total hip arthroplasty. Clin Orthop 1984; 188: 160–7
   Google Scholar
• Nilsson O S, Bauer H C F, Brosjo O, Tornkvist H. Influence of indomethacin on induced heterotopic bone formation in rats. Clin Orthop 1986; 207: 239–46
   PubMedGoogle Scholar
• NoUen A J G, Sloof T J J H. Paraarticular ossifications after total hip replacement. Acta Orthop Scand 1973; 44(2)230–41
   PubMedGoogle Scholar
• Reis H J, Kusswetter W, Schellinger T. The suppression of heterotopic ossification after total hip arthroplasty. Int Orthop 1992; 16(2)140–5
   PubMed Web of Science ®Google Scholar
• Ritter M A, Gioe T J. The effect of indomethacin on paraarticular ectopic ossification following total hip arthroplasty. Clin Orthop 1982; 167: 113–7
   Google Scholar
• Ritter M A, Sieber J M. Prophylactic indomethacin for the prevention of heterotopic bone formation following total hip arthroplasty. Clin Orthop 1985; 196: 217–25
   Google Scholar
• Schmidt S A, Kjaersgaard-Andersen P, Pedersen N W, Kristensen S S, Pedersen P, Nielsen J B. The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. A randomized, double-blind clinical trial. J Bone Joint Surg (Am) 1988; 70(6)834–8
   PubMed Web of Science ®Google Scholar
• Søballe K, Christensen F, Kristensen S S. Ectopic bone formation after total hip arthroplasty. Clin Othop 1988; 228: 57–62
   Google Scholar
• Törnkvist H, Bauer F C, Nilsson O S. Influence of Indomethacin on experimental bone metabolism in rats. Clin Orthop 1985; 193: 264–70
   PubMed Web of Science ®Google Scholar
• Wahlstrom O, Risto O, Djerf K. Hammerby S. Heterotopic bone formation prevented by diclofenac: prospective study of 100 hip arthroplasties. Acta Orthop Scand 1991; 62: 419–21
   PubMed Web of Science ®Google Scholar
• Wurnig C, Eyb R, Auersperg V. Indomethacin for prevention of ectopic ossification in cementless hip arthroplasties. A prospective 1 -year study of 100 cases. Acta Orthop Scand 1992; 63(6)628–30
   PubMedGoogle Scholar